[Federal Register Volume 71, Number 74 (Tuesday, April 18, 2006)]
[Notices]
[Page 19891]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-5792]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting; Interagency Autism Coordinating Committee

    The National Institutes of Health (NIH) hereby announces a meeting 
of the Interagency Autism Coordinating Committee to be held on May 9, 
2006, on the NIH campus in Bethesda, Maryland.
    The Children's Health Act of 2000 (Pub. L. 106-310), Title I, 
Section 104, mandated the establishment of an Interagency Autism 
Coordinating Committee (IACC) to coordinate autism research and other 
efforts within the Department of Health and Human Services (HHS). In 
April 2001, the Secretary of HHS delegated the authority to establish 
the IACC to the NIH. The National Institute of Mental Health (NIMH) at 
the NIH has been designated the lead for this activity.
    The IACC meeting will be open to the public, with attendance 
limited to space available. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the contact person listed 
below in advance of the meeting.
    Name of Committee: Interagency Autism Coordinating Committee.
    Date: May 9, 2006.
    Time: 9 a.m.-3:30 p.m.
    Agenda: Discussion of autism activities across Federal agencies.
    Place: National Institutes of Health, Building 31, Conference Room 
10 (6th floor), 31 Center Drive, Bethesda, Maryland 20892.
    Contact Person: Ann Wagner, PhD, Division of Pediatric 
Translational Research and Treatment Development, National Institute of 
Mental Health, NIH, 6001 Executive Boulevard, Room 6184, MSC 9617, 
Bethesda, Maryland 20892, E-mail: [email protected], Phone: 301-443-
5944.
    Any member of the public interested in presenting oral comments to 
the Committee may notify the contact person listed on this notice at 
least 5 days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a brief 
description of the organization represented, and a short description of 
the oral presentation. We may limit presentations to 5 minutes, and we 
request both printed and electronic copies for the record. In addition, 
any interested person may file written comments with the Committee by 
forwarding his or her statement to the contact person listed in this 
notice. The statement should include the name, address, telephone 
number, and, when applicable, the business or professional affiliation 
of the interested person.
    Information about the meeting and online registration forms are 
also available on the NIMH homepage at http://www.nimh.nih.gov/autismiacc/index.cfm.

    Dated: April 10, 2006.
Raynard S. Kington,
Deputy Director, National Institutes of Health.
 [FR Doc. E6-5792 Filed 4-17-06; 8:45 am]
BILLING CODE 4140-01-P